CI&T (NYSE:CINT – Get Free Report) had its target price reduced by research analysts at JPMorgan Chase & Co. from $6.00 to $5.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 38.47% from the stock’s previous close.
Other research analysts also recently issued research reports about the company. Wedbush downgraded CI&T from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $7.00 to $4.00 in a report on Tuesday, July 21st. Zacks Research downgraded CI&T from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 28th. TD Cowen decreased their price target on CI&T from $8.00 to $6.00 and set a “buy” rating on the stock in a report on Thursday, July 9th. Weiss Ratings lowered CI&T from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, June 29th. Finally, Wall Street Zen cut CI&T from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $6.19.
Read Our Latest Report on CINT
CI&T Price Performance
CI&T (NYSE:CINT – Get Free Report) last announced its earnings results on Tuesday, August 11th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). CI&T had a return on equity of 13.19% and a net margin of 7.90%.The company had revenue of $142.82 million for the quarter, compared to analyst estimates of $140.05 million. Equities research analysts predict that CI&T will post 0.32 EPS for the current fiscal year.
Institutional Investors Weigh In On CI&T
Large investors have recently bought and sold shares of the company. GMT Capital Corp bought a new position in shares of CI&T in the fourth quarter valued at $1,786,000. Royce & Associates LP raised its position in CI&T by 69.7% during the fourth quarter. Royce & Associates LP now owns 888,221 shares of the company’s stock worth $3,615,000 after acquiring an additional 364,696 shares in the last quarter. BW Gestao de Investimentos Ltda. raised its position in CI&T by 9.2% during the second quarter. BW Gestao de Investimentos Ltda. now owns 2,882,650 shares of the company’s stock worth $17,209,000 after acquiring an additional 242,811 shares in the last quarter. Marshall Wace LLP lifted its stake in CI&T by 90.4% in the second quarter. Marshall Wace LLP now owns 380,818 shares of the company’s stock valued at $2,273,000 after acquiring an additional 180,800 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in CI&T in the fourth quarter valued at $287,000. Institutional investors own 92.45% of the company’s stock.
More CI&T News
Here are the key news stories impacting CI&T this week:
- Positive Sentiment: CI&T reported 21.9% organic revenue growth in the second quarter, supported by momentum across geographies, industries and its client base. Revenue totaled approximately $142.8 million, exceeding the $140.1 million consensus estimate. CI&T Reports 21.9% Organic Revenue Growth in 2Q26
- Positive Sentiment: UBS lowered its price target from $7.20 to $6.20 but maintained a Buy rating. The revised target still implies substantial potential upside from the recent share price, signaling that UBS views the selloff as excessive relative to CI&T’s growth prospects. UBS price target update
- Neutral Sentiment: Full-year revenue guidance of $565.5 million to $577.8 million brackets the $570.0 million analyst consensus, suggesting management’s outlook is broadly in line with expectations. The available update did not provide a specific third-quarter or full-year EPS figure. CI&T earnings report
- Negative Sentiment: Second-quarter adjusted earnings were $0.07 per share, below the $0.09-$0.10 consensus estimate and unchanged from the year-ago period. The earnings miss indicates that strong sales growth has not yet translated into equivalent bottom-line expansion. CI&T Q2 Earnings Miss Estimates
- Negative Sentiment: The UBS price-target reduction may pressure sentiment despite the retained Buy rating, particularly because CINT trades well below its 50-day and 200-day moving averages and remains close to its 12-month low.
About CI&T
CI&T Inc (NYSE:CINT) is a global digital solutions and technology services provider specializing in end-to-end digital transformation. The company partners with clients across industries such as financial services, retail, healthcare and technology to deliver tailored software products, agile development practices and customer-centric design. Its core offerings include digital strategy consulting, user experience and interface design, cloud-native application development, data engineering and full-cycle product lifecycle management.
Leveraging a proprietary agile framework, CI&T helps organizations accelerate time-to-market and improve operational efficiency through continuous delivery and DevOps automation.
Read More
- Five stocks we like better than CI&T
- Tesla’s Robotaxi Reality Check: Time to Deliver
- Hims & Hers’ Revenue Beat Came With a Profitability Problem
- A Westinghouse IPO Could Reset the Nuclear Stock Conversation
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
Receive News & Ratings for CI&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI&T and related companies with MarketBeat.com's FREE daily email newsletter.
